DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Ding L, Kim HJ, Wang Q. et al.
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer.
Cell Rep 2018;
25: 2972-2980.e5
DOI: 10.1016/j.celrep.2018.11.054.
We do not assume any responsibility for the contents of the web pages of other providers.